The international Alzheimer research community is increasingly exploring alternatives to traditional medications. Alongside new antibody therapies, non-invasive methods and the preventive impact of existing vaccinations are coming into focus.
Acoustic Stimulation Shows Promising Results
A team from the Kunming Institute of Zoology in China employed targeted sound waves to combat protein deposits in the brain. A study published in July 2026 in PNAS demonstrated that after a week of daily one-hour sessions of 40-hertz sound exposure, beta-amyloid levels in the cerebrospinal fluid of rhesus monkeys doubled.
This suggests an enhanced removal of harmful deposits, and the effects remained stable for five weeks. Researchers view this as a cost-effective and safe alternative to expensive antibody treatments.
The German Society for Ultrasound in Medicine (DEGUM) also highlights MR-guided focused ultrasound (MRgFUS), which is already being used in Parkinson’s patients, showing sustained effects in the thalamus over time.
New Antibodies and Surprising Prevention
As of June 2026, two new antibody therapies, Lecanemab and Donanemab, became available in Germany. These specifically target amyloid plaques in the brain. It is estimated that around 120,000 of the 1.2 million Alzheimer patients in Germany qualify for this treatment.
While research for new solutions continues, you can already strengthen your cognitive fitness today. A free guide offers 11 practical everyday exercises specifically designed to help prevent dementia. Discover 11 Everyday Exercises for Dementia Prevention for Free
Other medications also show preventive potential. Data from the National Institutes of Health (NIH) indicates that SGLT2 inhibitors from diabetes therapy reduce the risk of Alzheimer’s by 43 percent, while GLP-1 agonists lower it by 33 percent.
Even vaccinations seem to offer protection. A study from Wales found that the shingles vaccine Shingrix reduced dementia risk by approximately 20% over seven years. High-dose flu vaccinations achieved a reduction of up to 55% within two years.
Enhanced Early Detection
Approximately 60% of dementia patients in Germany live without a formal diagnosis. This may soon change. AI-assisted retinal scans can identify risks up to 8.5 years before the first symptoms appear. Modern blood tests for the protein pTau217 are now over 90% accurate.
Many individuals notice cognitive changes only when the disease is already advanced. With this anonymous 2-minute self-assessment, based on seven scientifically validated questions, you can get a preliminary evaluation of your mental health. Start your Free Dementia Self-Test Here
Focusing on Risk Factors
Not everything that sounds beneficial is effective. A study published in June 2026 in Nature Metabolism by the University of Florida warns about glucosamine. This joint supplement apparently increases the risk of moving from mild cognitive impairment to Alzheimer’s disease by 25%.
Fish oil also disappointed in a double-blind study conducted by Keck Medicine of USC. While 365 participants took 2,000 mg of DHA daily, cognitive improvements were lacking, and the shrinkage of the hippocampus could not be halted.
Blood pressure is another vital factor. Researchers from Hallym University found that significant hypotension significantly raises Alzheimer’s risk, while hypertension increases the risk by a factor of 1.57. The takeaway is that prevention requires careful consideration, and not every seemingly healthy measure lives up to its promise.
